- Celularity (NASDAQ:CELU) has announced a $30M private offering priced at-the-market under Nasdaq rules.
- The clinical-stage biotechnology company entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of 4,054,055 shares of its Class A common stock at $7.40/share and warrants to purchase 4,054,055 shares of its Class A common stock at $8.25/share.
- The warrants will be exercisable immediately after the date of issuance and will expire five years following the initial issuance date.
- Gross proceeds will be ~$30M.
- The offering will close around May 20, 2022.
- CELU shares up around 2% pre-market